Page 111 - Read Online

Link et al. Roles of p53 in extrinsic factor-induced liver carcinogenesis

83. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC. cell survival. Mol Carcinog 2011;50:972-80.
Hepatitis B virus X protein inhibits p53 sequence-specific DNA 100. Zhu R, Mok MT, Kang W, Lau SS, Yip WK, Chen Y, Lai PB,
binding, transcriptional activity, and association with transcription Wong VW, To KF, Sung JJ, Cheng AS, Chan HL. Truncated HBx-
factor ERCC3. Proc Natl Acad Sci U S A 1994;91:2230-4. dependent silencing of GAS2 promotes hepatocarcinogenesis
84. Truant R, Antunovic J, Greenblatt J, Prives C, Cromlish JA. Direct through deregulation of cell cycle, senescence and p53-mediated
interaction of the hepatitis B virus HBx protein with p53 leads to apoptosis. J Pathol 2015;237:38-49.
inhibition by HBx of p53 response element-directed transactivation. 101. Long J, Wang Y, Li M, Tong WM, Jia JD, Huang J. Correlation
J Virol 1995;69:1851-9. of TP53 mutations with HCV positivity in hepatocarcinogenesis:
85. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan identification of a novel TP53 microindel in hepatocellular
CP, Geller DA, Will H, Harris CC. Hepatitis B virus X protein and carcinoma with HCV infection. Oncol Rep 2013;30:119-24.
p53 tumor suppressor interactions in the modulation of apoptosis. 102. Saitta C, Lanza M, Bertuccio A, Lazzara S, Navarra G, Raimondo
Proc Natl Acad Sci U S A 1997;94:14707-12. G, Pollicino T. Evaluation of CTNNB1 and TP53 variability in
86. Kuo TC, Chao CC. Hepatitis B virus X protein prevents apoptosis patients with hepatocellular carcinoma and occult hepatitis B virus
of hepatocellular carcinoma cells by upregulating SATB1 and infection. Cancer Genet 2015;208:513-6.
HURP expression. Biochem Pharmacol 2010;80:1093-102. 103. Amaddeo G, Cao Q, Ladeiro Y,Imbeaud S, Nault JC, Jaoui D,
87. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL. Hepatitis B Gaston Mathe Y, Laurent C, Laurent A, Bioulac-Sage P, Calderaro
virus X protein inhibits transforming growth factor-beta -induced J, Zucman-Rossi J. Integration of tumour and viral genomic
apoptosis through the activation of phosphatidylinositol 3-kinase characterisations in HBV-related hepatocellular carcinomas. Gut
pathway. J Biol Chem 2000;275:25858-64. 2015;64:820-9.
88. Kim H, Lee H, Yun Y. X-gene product of hepatitis B virus induces 104. Liu J, Ma Q, Zhang M, Wang X, Zhang D, Li W, Wang F, Wu E.
apoptosis in liver cells. J Biol Chem 1998;273:381-5. Alterations of TP53 are associated with a poor outcome for patients
89. Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, with hepatocellular carcinoma: evidence from a systematic review
Tiollais P, Buendia MA. p53-independent apoptotic effects of and meta-analysis. Eur J Cancer 2012;48:2328-38.
the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 105. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular
1998;17:2115-23. carcinoma. Gastroenterology 2012;142:1264-73.e1.
90. Schuster R, Gerlich WH, Schaefer S. Induction of apoptosis by 106. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global
the transactivating domains of the hepatitis B virus X gene leads epidemiology of hepatitis C virus infection: new estimates
to suppression of oncogenic transformation of primary rat embryo of age-specific antibody to HCV seroprevalence. Hepatology
fibroblasts. Oncogene 2000;19:1173-80. 2013;57:1333-42.
91. Wang Y, Lau SH, Sham JS, Wu MC, Wang T, Guan XY. 107. Choo QL, Richman KH, Han JH, Berger K, Lee C, Dong C,
Characterization of HBV integrants in 14 hepatocellular Gallegos C, Coit D, Medina-Selby R, Barr PJ. Genetic organization
carcinomas: association of truncated X gene and hepatocellular and diversity of the hepatitis C virus. Proc Natl Acad Sci U S A
carcinogenesis. Oncogene 2004;23:142-8. 1991;88:2451-5.
92. Ma NF, Lau SH, Hu L, Xie D, Wu J, Yang J, Wang Y, Wu MC, 108. Clarke B. Molecular virology of hepatitis C virus. J Gen Virol
Fung J, Bai X, Tzang CH, Fu L, Yang M, Su YA, Guan XY. 1997;78:2397-410.
COOH-terminal truncated HBV X protein plays key role in 109. Bukh J. The history of hepatitis C virus (HCV): basic research
hepatocarcinogenesis. Clin Cancer Res 2008;14:5061-8. reveals unique features in phylogeny, evolution and the viral
93. Liu LP, Hu BG, Ye C, Ho RL, Chen GG, Lai PB. HBx mutants life cycle with new perspectives for epidemic control. J Hepatol
differentially affect the activation of hypoxia-inducible factor- 2016;65:S2-21.
1alpha in hepatocellular carcinoma. Br J Cancer 2014;110:1066-73. 110. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M,
94. Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W, Häussinger
Paterlini-Bréchot P, Bréchot C, Kremsdorf D. Biological impact of D. Prognosis of chronic hepatitis C: results of a large, prospective
natural COOH-terminal deletions of hepatitis B virus X protein in cohort study. Hepatology 1998;28:1687-95.
hepatocellular carcinoma tissues. Cancer Res 2001;61:7803-10. 111. Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM,
95. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY,
C. Hepatitis B virus X mutants, present in hepatocellular carcinoma McGovern BH, Schinkel J, George J, Shoukry NH, Lauer GM,
tissue abrogate both the antiproliferative and transactivation effects Maher L, Lloyd AR, Hellard M, Dore GJ, Prins M; InC3 Study
of HBx. Oncogene 1999;18:4848-59. Group. The effects of female sex, viral genotype, and IL28B
96. Zhang H, Shan CL, Li N, Zhang X, Zhang XZ, Xu FQ, Zhang S, genotype on spontaneous clearance of acute hepatitis C virus
Qiu LY, Ye LH, Zhang XD. Identification of a natural mutant of infection. Hepatology 2014;59:109-20.
HBV X protein truncated 27 amino acids at the COOH terminal 112. Bartosch B, Thimme R, Blum HE, Zoulim F. Hepatitis C virus-
and its effect on liver cell proliferation. Acta Pharmacol Sin induced hepatocarcinogenesis. J Hepatol 2009;51:810-20.
2008;29:473-80. 113. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T,
97. Qian Y, Wang B, Ma A, Zhang L, Xu G, Ding Q, Jing T, Wu L, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The
Liu Y, Yang Z, Liu Y. USP16 downregulation by carboxyl-terminal core protein of hepatitis C virus induces hepatocellular carcinoma
truncated HBx promotes the growth of hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-7.
cells. Sci Rep 2016;6:33039. 114. Lemon SM, Lerat H, Weinman SA, Honda M. A transgenic mouse
98. Huo TI, Wang XW, Forgues M, Wu CG, Spillare EA, Giannini C, model of steatosis and hepatocellular carcinoma associated with
Brechot C, Harris CC. Hepatitis B virus X mutants derived from chronic hepatitis C virus infection in humans. Trans Am Clin
human hepatocellular carcinoma retain the ability to abrogate p53- Climatol Assoc 2000;111:146-56; discussion 156-7.
induced apoptosis. Oncogene 2001;20:3620-8. 115. Ivanov AV, Smirnova OA, Petrushanko IY, Ivanova ON, Karpenko
99. Iyer S, Groopman JD. Interaction of mutant hepatitis B X protein IL, Alekseeva E, Sominskaya I, Makarov AA, Bartosch B,
with p53 tumor suppressor protein affects both transcription and Kochetkov SN, Isaguliants MG. HCV core protein uses multiple
Hepatoma Research ¦ Volume 3 ¦ June 6, 2017 103